NasdaqGS:BCPC - 애널리스트의 미래 추정치 및 과거 재무 데이터 (USD Millions )
날짜	수익	수익	잉여 현금 흐름	작전 현금	평균 애널리스트 수
12/31/2026	1,061	168	196	239	1
12/31/2025	1,028	150	184	224	3
12/31/2024	960	127	139	179	3
6/30/2024	932	117	159	192	N/A
3/31/2024	930	115	147	182	N/A
12/31/2023	922	109	146	184	N/A
9/30/2023	926	103	118	158	N/A
6/30/2023	941	99	106	153	N/A
3/31/2023	946	99	117	166	N/A
12/31/2022	942	105	89	139	N/A
9/30/2022	923	109	91	141	N/A
6/30/2022	877	109	95	139	N/A
3/31/2022	842	102	86	127	N/A
12/31/2021	799	96	123	161	N/A
9/30/2021	767	93	128	164	N/A
6/30/2021	744	90	125	160	N/A
3/31/2021	715	88	134	169	N/A
12/31/2020	704	85	117	150	N/A
9/30/2020	689	83	108	136	N/A
6/30/2020	673	82	116	143	N/A
3/31/2020	661	81	99	125	N/A
12/31/2019	644	80	96	124	N/A
9/30/2019	641	80	103	131	N/A
6/30/2019	637	78	94	121	N/A
3/31/2019	639	78	91	116	N/A
12/31/2018	644	79	99	119	N/A
9/30/2018	639	100	87	110	N/A
6/30/2018	635	97	87	112	N/A
3/31/2018	618	94	N/A	113	N/A
12/31/2017	595	90	N/A	111	N/A
9/30/2017	576	64	N/A	107	N/A
6/30/2017	564	62	N/A	97	N/A
3/31/2017	556	60	N/A	101	N/A
12/31/2016	553	56	N/A	108	N/A
9/30/2016	545	56	N/A	105	N/A
6/30/2016	547	56	N/A	110	N/A
3/31/2016	543	56	N/A	107	N/A
12/31/2015	552	60	N/A	104	N/A
9/30/2015	582	63	N/A	115	N/A
6/30/2015	603	64	N/A	108	N/A
3/31/2015	600	59	N/A	102	N/A
12/31/2014	541	53	N/A	85	N/A
9/30/2014	460	45	N/A	65	N/A
6/30/2014	387	41	N/A	60	N/A
3/31/2014	339	43	N/A	62	N/A
12/31/2013	337	45	N/A	56	N/A

애널리스트 미래 성장 예측

수입 대 저축률: BCPC 의 연간 예상 수익 증가율( 15.2% )이 saving rate( 2.5% 보다 높습니다. ).

수익 vs 시장: BCPC 의 연간 수익( 15.2% ) US 시장( 15.2% 보다 느리게 성장할 것으로 예상됩니다. 15.2% 연간).

고성장 수익: BCPC 의 수입은 증가할 것으로 예상되지만 상당히 증가하지는 않을 것입니다.

수익 대 시장: BCPC 의 수익(연간 5.7% ) US 시장( 8.8% 보다 느리게 성장할 것으로 예상됩니다. 8.8% 연간).

고성장 수익: BCPC 의 수익(연간 5.7% )은 연간 20% 보다 느리게 증가할 것으로 예상됩니다.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: BCPC 의 자본 수익률은 3년 내에 최저 수준이 될 것으로 예상됩니다( 12.5 %).

Balchem 미래 성장

Future 기준 확인 1/6

주요 정보

최근 미래 성장 업데이트

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Price target increased by 11% to US$184

Price target increased by 14% to US$166

Price target decreased by 8.4% to US$145

Price target increased to US$170

Price target increased to US$154

Recent updates

Is Balchem (NASDAQ:BCPC) Using Too Much Debt?

Here's Why We Think Balchem (NASDAQ:BCPC) Might Deserve Your Attention Today

Balchem Corporation's (NASDAQ:BCPC) Shares May Have Run Too Fast Too Soon

VP & Chief Accounting Officer notifies of intention to sell stock

Earnings Update: Here's Why Analysts Just Lifted Their Balchem Corporation (NASDAQ:BCPC) Price Target To US$184

Price target increased by 11% to US$184

Second quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Balchem Corporation to Report Q2, 2024 Results on Jul 26, 2024

Return Trends At Balchem (NASDAQ:BCPC) Aren't Appealing

Shareholders Will Most Likely Find Balchem Corporation's (NASDAQ:BCPC) CEO Compensation Acceptable

Calculating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Insider notifies of intention to sell stock

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Independent Director recently sold US$765k worth of stock

Independent Director notifies of intention to sell stock

Balchem: A Tale Of Two Businesses

Price target increased by 14% to US$166

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 21% overvalued after recent price rise

Balchem Corporation, Annual General Meeting, Jun 20, 2024

Balchem Corporation to Report Q1, 2024 Results on May 03, 2024

Balchem Corporation's (NASDAQ:BCPC) Popularity With Investors Is Clear

Is Balchem Corporation (NASDAQ:BCPC) Expensive For A Reason? A Look At Its Intrinsic Value

Chairman recently sold US$4.6m worth of stock

Chairman notifies of intention to sell stock

Balchem: Potential Turnaround Is In The Price

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Reasonably Well

Full year 2023 earnings: EPS misses analyst expectations

Now 21% overvalued after recent price rise

Balchem Corporation to Report Q4, 2023 Results on Feb 16, 2024

Returns On Capital At Balchem (NASDAQ:BCPC) Have Stalled

Upcoming dividend of US$0.79 per share at 0.5% yield

Balchem Corporation's (NASDAQ:BCPC) P/E Is On The Mark

Balchem Corporation Announces Dividend, Payable on January 19, 2024

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Price target decreased by 8.4% to US$145

Third quarter 2023 earnings: EPS in line with expectations, revenues disappoint

Balchem (NASDAQ:BCPC) Has A Pretty Healthy Balance Sheet

Balchem Corporation to Report Q3, 2023 Results on Oct 27, 2023

Independent Director recently sold US$500k worth of stock

The Returns At Balchem (NASDAQ:BCPC) Aren't Growing

Balchem Corporation Announces Board Appointments, Effective as of September 6, 2023

A Look At The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Second quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation to Report Q2, 2023 Results on Jul 28, 2023

Some Investors May Be Worried About Balchem's (NASDAQ:BCPC) Returns On Capital

Calculating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Senior VP & CTO recently sold US$300k worth of stock

First quarter 2023 earnings: EPS exceeds analyst expectations

Do Balchem's (NASDAQ:BCPC) Earnings Warrant Your Attention?

Independent Director recently sold US$381k worth of stock

We Think Balchem (NASDAQ:BCPC) Can Stay On Top Of Its Debt

Full year 2022 earnings: EPS misses analyst expectations

Balchem Corporation to Report Q4, 2022 Results on Feb 24, 2023

Balchem (NASDAQ:BCPC) Hasn't Managed To Accelerate Its Returns

Here's Why We Think Balchem (NASDAQ:BCPC) Is Well Worth Watching

Upcoming dividend of US$0.71 per share

Is Balchem (NASDAQ:BCPC) A Risky Investment?

Balchem Corporation Announces Dividend, Payable on January 20, 2023

Balchem Corporation (NASDAQ:BCPC) Shares Could Be 26% Above Their Intrinsic Value Estimate

Insufficient new directors

Third quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Insufficient new directors

Balchem Corporation to Report Q3, 2022 Results on Nov 04, 2022

Insufficient new directors

James C. Hyde, Senior Vice President and General Manager, Human Nutrition & Health, Notifies Balchem Corporation His Intent to Retire from His Role

Here's What To Make Of Balchem's (NASDAQ:BCPC) Decelerating Rates Of Return

Balchem: Acquisitions And Cost Pressures Draw Attention